Compare EOLS & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EOLS | TLRY |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | Canada |
| Employees | N/A | 3595 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 550.9M | 560.3M |
| IPO Year | 2018 | 2018 |
| Metric | EOLS | TLRY |
|---|---|---|
| Price | $8.00 | $3.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $15.50 | ★ $72.33 |
| AVG Volume (30 Days) | 912.2K | ★ 3.4M |
| Earning Date | 05-04-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.23 | ★ 55.69 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $297,176,000.00 | N/A |
| Revenue This Year | $13.27 | $8.79 |
| Revenue Next Year | $17.62 | $19.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 11.61 | N/A |
| 52 Week Low | $3.86 | $0.77 |
| 52 Week High | $9.31 | $15.70 |
| Indicator | EOLS | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 45.18 | 34.98 |
| Support Level | $5.78 | $3.67 |
| Resistance Level | $8.43 | $4.91 |
| Average True Range (ATR) | 0.36 | 0.19 |
| MACD | -0.21 | -0.07 |
| Stochastic Oscillator | 18.60 | 2.27 |
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
Tilray is as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top, 10 Barrell, Breckenridge Brewery, Blue Point Brewing, Breckenridge Distillery, Revolver, Terrapin, Broken Coast, Good Supply, Redecan, Solei, Tilray, ARX, XMG, Manitoba Harvest and Hi-Ball. The company has four segment Beverage, Cannabis, Distribution and Wellness. The majority of the revenue is generated from Distribution business which encompasses the purchase and resale of pharmaceuticals products to customers.